ZA200301437B - Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies. - Google Patents

Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies. Download PDF

Info

Publication number
ZA200301437B
ZA200301437B ZA200301437A ZA200301437A ZA200301437B ZA 200301437 B ZA200301437 B ZA 200301437B ZA 200301437 A ZA200301437 A ZA 200301437A ZA 200301437 A ZA200301437 A ZA 200301437A ZA 200301437 B ZA200301437 B ZA 200301437B
Authority
ZA
South Africa
Prior art keywords
peptide
peptides
cyclised
carrier
vaccine
Prior art date
Application number
ZA200301437A
Other languages
English (en)
Inventor
Martin Friede
William Gordon Turnell
Sean Mason
Carlota Vinals Y De Bassols
Original Assignee
Glaxosmithkline Biolog Sa
Acambis Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa, Acambis Res Ltd filed Critical Glaxosmithkline Biolog Sa
Publication of ZA200301437B publication Critical patent/ZA200301437B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA200301437A 2000-08-22 2003-02-21 Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies. ZA200301437B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0020717.5A GB0020717D0 (en) 2000-08-22 2000-08-22 Novel compounds and process

Publications (1)

Publication Number Publication Date
ZA200301437B true ZA200301437B (en) 2004-05-21

Family

ID=9898110

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200301437A ZA200301437B (en) 2000-08-22 2003-02-21 Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies.

Country Status (17)

Country Link
US (1) US20040030106A1 (pl)
EP (1) EP1311536A2 (pl)
JP (1) JP2004514655A (pl)
KR (1) KR20030062405A (pl)
CN (1) CN1471539A (pl)
AR (1) AR030458A1 (pl)
AU (1) AU2002214951A1 (pl)
BR (1) BR0113439A (pl)
CA (1) CA2420086A1 (pl)
GB (1) GB0020717D0 (pl)
HU (1) HUP0301725A3 (pl)
IL (1) IL154532A0 (pl)
MX (1) MXPA03001631A (pl)
NO (1) NO20030822L (pl)
PL (1) PL365788A1 (pl)
WO (1) WO2002016409A2 (pl)
ZA (1) ZA200301437B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0026334D0 (en) * 2000-10-27 2000-12-13 Smithkline Beecham Biolog Vaccine
GB0209878D0 (en) * 2002-04-30 2002-06-05 Glaxosmithkline Biolog Sa Vaccine
CN102702359A (zh) * 2004-02-02 2012-10-03 泰勒公司 新的IgE表位的鉴别
KR101399175B1 (ko) * 2006-07-21 2014-06-19 푼다싸웅 지 앙빠루 아 뻬스끼자 두 에스따두 지 싸웅 파울루 - 에피아뻬에에씨뻬 항염증성 및 항알레르기성 시클릭 펩티드
CN101511861B (zh) * 2006-07-21 2013-04-24 克里斯泰利亚化学药物产品有限公司 抗炎和抗过敏的环肽
JP2009544697A (ja) * 2006-07-26 2009-12-17 ペプスキャン システムズ ベー．フェー． 免疫原性化合物及びタンパク質擬態物
BR112012011055A2 (pt) * 2009-11-16 2019-09-24 Hoffmann La Roche reagente de calibração metodo para gerar uma curva padrão metodo pata qualificar a concetração de uma proteina metodo para determinar o limite inferior de detecção de um reagente de afinidade de interesse metodo para determinar a sensibilidade do reagente de afinidade de interesse metodo para determinar a faixa dinamica de um reagente de afinidade de interesse metodo para determinar a especialidade de um reagente de afinidade de interesse uso do reagente de calibração e proteinas peptideos metodos e uso
PL2458467T3 (pl) 2010-11-26 2014-03-31 Abb Research Ltd Sposób i system do monitorowania systemu przemysłowego
CN106366160B (zh) * 2016-10-11 2019-06-14 厦门大学 基于二硫键精准配对构建富含二硫键多肽分子骨架的方法
CN111936856A (zh) * 2018-04-06 2020-11-13 Sls生物有限公司 新型免疫球蛋白e的表位、与其结合的抗体及包括所述抗体的用于分析试料中免疫球蛋白e的试剂盒
WO2025100514A1 (ja) * 2023-11-09 2025-05-15 株式会社ファンペップ 抗ＩｇＥ抗体誘導用ワクチン組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981979A (en) * 1987-09-10 1991-01-01 Neorx Corporation Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
TWI227241B (en) * 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate

Also Published As

Publication number Publication date
US20040030106A1 (en) 2004-02-12
CA2420086A1 (en) 2002-02-28
NO20030822D0 (no) 2003-02-21
NO20030822L (no) 2003-03-31
PL365788A1 (pl) 2005-01-10
GB0020717D0 (en) 2000-10-11
JP2004514655A (ja) 2004-05-20
CN1471539A (zh) 2004-01-28
AU2002214951A1 (en) 2002-03-04
BR0113439A (pt) 2004-07-06
IL154532A0 (en) 2003-09-17
HUP0301725A2 (hu) 2003-08-28
EP1311536A2 (en) 2003-05-21
KR20030062405A (ko) 2003-07-25
WO2002016409A2 (en) 2002-02-28
AR030458A1 (es) 2003-08-20
HUP0301725A3 (en) 2004-11-29
MXPA03001631A (es) 2004-09-10
WO2002016409A3 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
JP4087898B2 (ja) 免疫原性に乏しい抗原と合成ペプチド担体との結合体およびそれらからなるワクチン
EP1155038A1 (en) Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
JP2003231696A (ja) ペプチド免疫原
US20040030106A1 (en) Novel compounds and process
Zhang et al. Moderate PEGylation of the carrier protein improves the polysaccharide-specific immunogenicity of meningococcal group A polysaccharide conjugate vaccine
WO2003092714A2 (en) Peptide variants of ige constrained by beta-lactam bond
KR20020007313A (ko) ＩｇＥ의 Ｃ-엡실론-2 도메인으로부터 유도된 에피토프또는 미모토프, 이들의 길항제 및 이들의 치료학적 용도
JP2002537354A (ja) ペプチド、及びＨ．ｉｎｆｌｕｅｎｚａｅのプロテインＤ由来の担体を含む免疫原
US20040115220A1 (en) Vaccine
US20030170229A1 (en) Vaccine
US20050152892A1 (en) Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutics uses
US20050214285A1 (en) Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic uses
JP2002540217A (ja) イヌアレルギー用ペプチドワクチン
Kaushik et al. Synthesis of peptide based epsilon toxin vaccine by covalent anchoring to tetanus toxoid
US20180186896A1 (en) Vaccines for the treatment and prevention of ige mediated diseases
CA2144936A1 (en) Antibody conjugates with improved properties
MXPA00011938A (en) Peptide composition as immunogen for the treatment of allergy
EP0674907A2 (en) Conjugabes of a antibody and a carrier protein, useful for active immunotherapy
NZ286599A (en) use of protein antibody conjugate for stimulating an immune response